Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927); mRNA-3927 is Moderna's second rare disease program to receive Fast Track designation; mRNA-3927 uses the same proprietary LNP formulation as mRNA-1944 (antibody agains

  • George Diaz

Press/Media

Period22 Oct 2019

Media coverage

3

Media coverage